These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9082380)

  • 21. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
    Black KJ; Racette B; Perlmutter JS
    Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current classifications of dystonies, treatment strategy].
    Zalialova ZA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):85-9. PubMed ID: 23612417
    [No Abstract]   [Full Text] [Related]  

  • 23. Joint hypermobility syndrome: a risk factor for fixed dystonia?
    Kassavetis P; Batla A; Pareés I; Saifee TA; Schrag A; Cordivari C; Bhatia KP; Edwards MJ
    Mov Disord; 2012 Jul; 27(8):1070. PubMed ID: 22532260
    [No Abstract]   [Full Text] [Related]  

  • 24. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
    Müller J; Wenning GK; Wissel J; Seppi K; Poewe W
    J Neurol; 2002 Mar; 249(3):300-4. PubMed ID: 11993530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin: a poison transformed into a versatile tool.
    Mahajan S; Srivastava V
    Eur J Esthet Dent; 2010; 5(4):327-9. PubMed ID: 21069104
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options.
    Balash Y; Giladi N
    Eur J Neurol; 2004 Jun; 11(6):361-70. PubMed ID: 15171731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On muscle spindles, dystonia and botulinum toxin.
    Rosales RL; Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed-onset focal dystonia of the leg secondary to traumatic brain injury.
    Kemp S; Kim SD; Cordato DJ; Fung VS
    J Clin Neurosci; 2012 Jun; 19(6):916-7. PubMed ID: 22341145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Jaw-opening dystonia: Quality of life after botulinum toxin injections.
    Charous SJ; Comella CL; Fan W
    Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The moving ear syndrome: a focal dyskinesia.
    Chaudhuri KR; Leigh PN; Gibb WR; Pye IF
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):106. PubMed ID: 8558136
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
    Gudex CM; Hawthorne MR; Butler AG; Duffey P
    Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years' experience with botulin toxin in anal fissure.
    Jost WH
    Int J Colorectal Dis; 2002 Sep; 17(5):298-302. PubMed ID: 12172922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Botulinum toxin--from threat to cure].
    Odergren T; Lennerstrand G; Lindestad PA; Hertegård S; Borg J
    Lakartidningen; 1996 Apr; 93(17):1619-24. PubMed ID: 8667769
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical syndrome of primary tic disorder associated with dystonia: a large clinical series and a review of the literature.
    Damásio J; Edwards MJ; Alonso-Canovas A; Schwingenschuh P; Kägi G; Bhatia KP
    Mov Disord; 2011 Mar; 26(4):679-84. PubMed ID: 21506147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal perception of vibration-induced illusion of movement in dystonia.
    Rome S; Grünewald RA
    Neurology; 1999 Nov; 53(8):1794-800. PubMed ID: 10563630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of botulinum toxin in the treatment of cervical dystonia.
    Molho E; Jankovic J; Lew M
    Neurol Clin; 2008 May; 26 Suppl 1():43-53. PubMed ID: 18603167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.